Olga Kolaj-Robin European Directorate for the Quality of Medicines and HealthCare

Olga Kolaj-Robin joined the European Pharmacopoeia Department of the European Directorate for the Quality of Medicines and Healthcare in 2015 where she works as Scientific Programme Manager coordinating the work of European Pharmacopoeia Groups of Experts and Working Parties. In particular, since its reinstatement in 2018 by the European Pharmacopoeia Commission, she coordinates the activities of Gene Therapy Products Working Party in charge of elaboration and maintenance of pharmacopoeial texts in the field of gene therapy. She holds a PhD in in Protein Biochemistry from University of Limerick (Ireland) and a MS in Molecular Biotechnology from Gdansk University of Technology (Poland).